B2M and cancer: To date, antiphagocytic surface proteins identified on cancer cells include CD47 [30], programmed cell death ligand 1 (PD-L1) [31], beta-2 macroglobulin subunit of the major histocompatibility class I complex (B2M) [32]and CD24 [7].